# Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason

> **NCT03492944** · — · ACTIVE_NOT_RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 25 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Ultrasound Microbubble Contrast Agent
- **DEVICE:** Ultrasound Imaging

## Key facts

- **NCT ID:** NCT03492944
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-03-06
- **Primary completion:** 2024-06-12
- **Final completion:** 2026-02
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03492944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03492944, "Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT03492944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*